Articles related to COVID-19

In a revealing study, researchers found a higher incidence of long-COVID symptoms in patients who received two COVID-19 vaccine doses, challenging previous perceptions and highlighting the need for deeper understanding in post-COVID care.

New research suggests that the COVID-19 virus and its remnant spike protein may bind to and kill lymphocytes, leading to lymphopenia.

A recent study found a 69 percent increased risk of Alzheimer’s diagnosis within a year of COVID-19 infection in individuals aged 65 years and older. This significant link between viral infections and Alzheimer’s disease could have major implications for our understanding of neurodegenerative diseases and their treatment.

The escalating crisis of burnout among oncology healthcare workers is a pressing issue that demands immediate attention. With up to 54% of doctors and nurses experiencing burnout, the need for systemic changes in the healthcare landscape has never been more urgent.

The “revolving door” phenomenon, exemplified by the transition of Doran Fink from the FDA to Moderna, raises critical questions about public trust and regulatory integrity. As healthcare professionals, understanding these dynamics can inform our perspectives on regulatory processes and pharmaceutical industry relationships.

The potential of the antiviral combo in reducing the risk of thromboembolic events among post-COVID-19 patients is real. Could it pave the way for more targeted therapeutic strategies in managing post-COVID-19 conditions?